No Detail Found!

Comparison of Efficacy of Nebulized Salbutamol with Salbutamol / Ipratropium Combination in Acute Exacerbation of Chronic Obstructive Pulmonary Disease

Author(s)
Muhammad Nadeem Ashraf Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Muhammad Arif Khan epartment of Medicine, Combine Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Muhammad Imran Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Imran Fazal Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Zubia Hassan Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi,,Pakistan
Laima Alam Department of Medicine, Pak Emirate Military Hospital/National University of Medical Sciences (NUMS) Rawalpindi Pakistan
Abstract
Objectives: To compare the nebulized salbutamol alone with combination of nebulized salbutamol and ipratropium for acute exacerbation of chronic obstructive pulmonary disease in terms of mean length of stay. Study Design: Quasi-experimental study Place and Duration of Study: Department of Medicine, Military Hospital, Rawalpindi Pakistan. Study was carried out over a period of six months from May to Nov 2017. Methodology: A total of 300 patients of chronic obstructive pulmonary disease (150 in each group) were recruited in the study. Group A received nebulized salbutamol (5mg) alone and Group B received a combination of nebulized salbutamol (5mg) and ipratropium bromide (0.5mg). Results: Mean age of the patients was 66.4±6.4 years and 65.7±6.8 years in Group-A and B, respectively. In Group-A, there were 136(90.7%) and in Group-B 134(89.3%) were males while 14(9.3%) and 16(10.7%) were females in Group-A and B, respectively. Mean duration of disease in Group-A was 5.2±2.4 years and in group-B 6.0±1.6 years. Comparison of mean length of stay (days) revealed in hospital between nebulized Salbutamol alone 5.0±0.5 days with combination of nebulized Salbutamol and Ipratropium 4.3±0.6 days with p-value <0.001. Conclusion: In conclusion, the routine addition of nebulized ipratropium bromide to salbutamol appears to be of benefit in the treatment of acute exacerbations of chronic obstructive pulmonary disease and in terms of mean length of hospital stay. 
Publication Details
Page(s) 36-39
Published Journal: Pakistan Armed Forces Medical Journal, Volume: 73, Issue: S1, Year: 2023

Request the full text from PASTIC

Keywords
Salbutamol, Ipratropium, Acute exacerbation of chronic obstructive pulmonary disease
0

Citations

0

Downloads

101

Views